March 15, 2017
The Ministry of Health, Labor and Welfare (MHLW) issued a business improvement order to Celgene on March 14 over a violation of reporting requirements related to over 4,500 possible side effect cases involving Revlimid (lenalidomide) and two other drugs. Celgene...read more